Day

August 27, 2019
LikeMinds is developing a brain imaging agent that is intended to support the early diagnosis of dopamine mediated neurological diseases such as Parkinson’s, Alzheimer’s, ADHD, depression, addiction and schizophrenia. The facts are clear: 68.5 million Americans require accurate, precise diagnosis of degenerative brain diseases yet current imaging tools lack the required precision and economic value...
Read More